|
Apr 24
|
Can Biogen Keep the Beat Streak Alive This Earnings Season?
|
|
Apr 23
|
AstraZeneca pushes EU to spend more on drugs amid Trump tariffs threat
|
|
Apr 23
|
Drug firm bosses call for price increases in Europe amid tariff uncertainty
|
|
Apr 23
|
Why Tempus AI Stock Is Skyrocketing Today
|
|
Apr 22
|
Astrazeneca (AZN) Rises But Trails Market: What Investors Should Know
|
|
Apr 22
|
AstraZeneca rejoins leading U.S. drug lobby group after two-year absence
|
|
Apr 22
|
Daiichi and AstraZeneca’s Enhertu shows PFS benefits in breast cancer trial
|
|
Apr 21
|
Cellectis SA (CLLS) Q4 2024 Earnings Call Highlights: Strategic Collaborations and Financial ...
|
|
Apr 21
|
AstraZeneca (LSE:AZN) and Daiichi Sankyo's ENHERTU Shows Promising Results in HER2 Breast Cancer Trial
|
|
Apr 21
|
Should You Buy, Sell or Hold AstraZeneca Stock Before Q1 Earnings?
|
|
Apr 21
|
AstraZeneca- Daiichi Sankyo's Multi-Billion Dollar Cancer Drug Shows Superior Efficacy Across Broad HER2 Positive Metastatic Breast Cancer Patients
|
|
Apr 21
|
ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival vs. THP as 1st-line therapy for patients with HER2+ metastatic breast cancer
|
|
Apr 15
|
Is AstraZeneca PLC (AZN) the Best Pharma Stock to Buy for Long Term Growth?
|
|
Apr 15
|
Tariff wars to hit popular US-made drugs in China, regulator data shows
|
|
Apr 14
|
Is AstraZeneca (AZN) The Best UK Stock to Buy According to Billionaires?
|
|
Apr 14
|
Nasdaq Bear Market: 3 Unstoppable Stocks You Can Buy With $300 Right Now
|
|
Apr 14
|
The Zacks Analyst Blog AbbVie's, Rinvoq and AstraZeneca's and Novartis
|
|
Apr 11
|
Pharma Stock Roundup: EU Nod to Expanded Use of ABBV, AZN Drugs & More
|
|
Apr 11
|
AstraZeneca’s oral breast cancer drug Truqap greenlit for NHS use
|
|
Apr 10
|
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
|